Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.99 USD | +1.91% | +0.50% | +147.37% |
Apr. 10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
Mar. 18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
Financials (USD)
Sales 2024 * | 117M | Sales 2025 * | 234M | Capitalization | 923M |
---|---|---|---|---|---|
Net income 2024 * | -229M | Net income 2025 * | -143M | EV / Sales 2024 * | 5.9 x |
Net cash position 2024 * | 231M | Net cash position 2025 * | 228M | EV / Sales 2025 * | 2.97 x |
P/E ratio 2024 * |
-3.36
x | P/E ratio 2025 * |
-6.37
x | Employees | 296 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.88% |
Latest transcript on Arcutis Biotherapeutics, Inc.
1 day | +1.91% | ||
1 week | +0.50% | ||
Current month | -3.97% | ||
1 month | -21.67% | ||
3 months | +15.80% | ||
6 months | +278.67% | ||
Current year | +147.37% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 55 | 15-12-31 |
Rajvir Madan
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Jay Ramsinghani
COO | Chief Operating Officer | - | 20-05-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Heron
CHM | Chairman | 53 | 16-03-31 |
Founder | 69 | 16-05-31 | |
Keith Leonard
BRD | Director/Board Member | 62 | 21-09-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 7.99 | +1.91% | 2,339,107 |
24-05-10 | 7.84 | -2.24% | 2,539,114 |
24-05-09 | 8.02 | +0.38% | 2,904,968 |
24-05-08 | 7.99 | +1.40% | 2,335,950 |
24-05-07 | 7.88 | -0.88% | 1,644,950 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+147.37% | 923M | |
+5.66% | 111B | |
+11.23% | 105B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- ARQT Stock